|
|
| Master the new challenges facing medical affairs groups
Most medical affairs groups have grown comfortable abiding by new regulations developed over the past several years. With this transition out of the way, they now focus on the ultimate goals of any medical group - to generate, package and disseminate medical and clinical information for both internal and external clients. To accomplish this mission, the modern medical affairs department has evolved into a global group charged with a growing number of specialized responsibilities in regions all over the world. With so many tasks at hand, teams face a new challenge: how do they allocate resources in a manner that allows each sub-function to meet its goals and grow with the demands of the medical community? This report is designed to help all biopharmaceutical companies, regardless of size or geography, distribute medical resources efficiently while providing top-tier support for all stakeholders. Build global, US and affiliate medical budgets Explore detailed resource data for entire medical groups and 11 critical sub-functions. Track spending from 2009 through 2011 to see where budgets are climbing - and where they're stagnant or declining. Manage the expanding stable of medical sub-functions Staff a spectrum of medical tasks and teams, from thought leader development and MSL forces to medical education and investigator-initiated trial management. Leverage benchmarks and team profiles to put the puzzle together for your medical group. Map the new medical affairs universe With reorganizations complete, medical now sits at the nexus of commercial and R&D concerns. Managing the reconfigured medical group is the next challenge. Align your team with the industry's most pressing priorities, plan for future growth and reinforce medical's position as a major function area across all life science sectors. |
Related Markets
Regulation & Policy Reports
- Healthcare, Regulatory and Reimbursement Landscape - Malaysia
- The Healcare Market in the BRIC and Other Countries - The Healcare Systems, Market Access and Market Opportunities
- Healthcare, Regulatory and Reimbursement Landscape - Singapore
- Healthcare, Regulatory and Reimbursement Landscape - Brazil
- Healthcare, Regulatory and Reimbursement Landscape - China
